CN1319605C - Collagen-chitin and silicon rubber bilayer skin regeneration support and its preparation method - Google Patents
Collagen-chitin and silicon rubber bilayer skin regeneration support and its preparation method Download PDFInfo
- Publication number
- CN1319605C CN1319605C CNB200510061872XA CN200510061872A CN1319605C CN 1319605 C CN1319605 C CN 1319605C CN B200510061872X A CNB200510061872X A CN B200510061872XA CN 200510061872 A CN200510061872 A CN 200510061872A CN 1319605 C CN1319605 C CN 1319605C
- Authority
- CN
- China
- Prior art keywords
- collagen
- chitin
- chitosan
- silicon rubber
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229920002379 silicone rubber Polymers 0.000 title claims abstract description 61
- 230000036560 skin regeneration Effects 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 229920002101 Chitin Polymers 0.000 title claims description 19
- 229920001661 Chitosan Polymers 0.000 claims abstract description 76
- 102000008186 Collagen Human genes 0.000 claims abstract description 37
- 108010035532 Collagen Proteins 0.000 claims abstract description 37
- 229920001436 collagen Polymers 0.000 claims abstract description 36
- 239000000853 adhesive Substances 0.000 claims abstract description 19
- 230000001070 adhesive effect Effects 0.000 claims abstract description 18
- 239000000243 solution Substances 0.000 claims description 47
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 14
- 210000004207 dermis Anatomy 0.000 claims description 11
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 108010010803 Gelatin Proteins 0.000 claims description 6
- 239000008273 gelatin Substances 0.000 claims description 6
- 229920000159 gelatin Polymers 0.000 claims description 6
- 235000019322 gelatine Nutrition 0.000 claims description 6
- 235000011852 gelatine desserts Nutrition 0.000 claims description 6
- 238000004132 cross linking Methods 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 4
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 claims description 3
- 238000007710 freezing Methods 0.000 claims description 3
- 230000008014 freezing Effects 0.000 claims description 3
- 239000003292 glue Substances 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- RPQUGMLCZLGZTG-UHFFFAOYSA-N octyl cyanoacrylate Chemical compound CCCCCCCCOC(=O)C(=C)C#N RPQUGMLCZLGZTG-UHFFFAOYSA-N 0.000 claims description 3
- JJJFUHOGVZWXNQ-UHFFFAOYSA-N enbucrilate Chemical compound CCCCOC(=O)C(=C)C#N JJJFUHOGVZWXNQ-UHFFFAOYSA-N 0.000 claims description 2
- 238000004140 cleaning Methods 0.000 claims 2
- 239000011248 coating agent Substances 0.000 claims 2
- 238000000576 coating method Methods 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 239000004945 silicone rubber Substances 0.000 abstract description 44
- 210000001519 tissue Anatomy 0.000 abstract description 13
- 230000007547 defect Effects 0.000 abstract description 9
- 210000002615 epidermis Anatomy 0.000 abstract description 9
- 230000002500 effect on skin Effects 0.000 abstract description 6
- 239000002131 composite material Substances 0.000 abstract description 4
- 230000008929 regeneration Effects 0.000 abstract description 4
- 238000011069 regeneration method Methods 0.000 abstract description 4
- 230000015556 catabolic process Effects 0.000 abstract description 3
- 238000006731 degradation reaction Methods 0.000 abstract description 3
- 241000894006 Bacteria Species 0.000 abstract description 2
- 238000011065 in-situ storage Methods 0.000 abstract description 2
- 230000009545 invasion Effects 0.000 abstract description 2
- 230000035755 proliferation Effects 0.000 abstract description 2
- 230000024245 cell differentiation Effects 0.000 abstract 1
- 230000005012 migration Effects 0.000 abstract 1
- 238000013508 migration Methods 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 230000037314 wound repair Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 28
- 208000027418 Wounds and injury Diseases 0.000 description 11
- 238000004108 freeze drying Methods 0.000 description 11
- 206010052428 Wound Diseases 0.000 description 10
- 230000006870 function Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 210000002950 fibroblast Anatomy 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 4
- 210000001339 epidermal cell Anatomy 0.000 description 4
- 238000002386 leaching Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 238000009849 vacuum degassing Methods 0.000 description 4
- 230000029663 wound healing Effects 0.000 description 4
- 102000012422 Collagen Type I Human genes 0.000 description 3
- 108010022452 Collagen Type I Proteins 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 230000008952 bacterial invasion Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 210000002744 extracellular matrix Anatomy 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- IJVRPNIWWODHHA-UHFFFAOYSA-N 2-cyanoprop-2-enoic acid Chemical compound OC(=O)C(=C)C#N IJVRPNIWWODHHA-UHFFFAOYSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 102000016611 Proteoglycans Human genes 0.000 description 2
- 108010067787 Proteoglycans Proteins 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- 239000004830 Super Glue Substances 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000004177 elastic tissue Anatomy 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 102000006495 integrins Human genes 0.000 description 2
- 108010044426 integrins Proteins 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 231100001083 no cytotoxicity Toxicity 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000004215 skin function Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 108010072041 arginyl-glycyl-aspartic acid Proteins 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000006196 deacetylation Effects 0.000 description 1
- 238000003381 deacetylation reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000007646 directional migration Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
Abstract
本发明公开了一种胶原-壳聚糖和硅橡胶双层皮肤再生支架及其制备方法。该皮肤再生支架由胶原/壳聚糖多孔支架和硅橡胶薄膜通过生物相容性良好的胶粘剂粘结而成。其中胶原/壳聚糖多孔支架可以有效诱导缺损组织处细胞的迁移、增殖和分化,原位诱导缺损真皮组织的再生;硅橡胶薄膜则起到了临时表皮层的作用,可以有效控制水分的挥发和防止细菌的侵入等,对创面起到了临时保护作用。本发明所制备的胶原—壳聚糖/硅橡胶复合支架具有良好的生物相容性,可控的降解速率和优异的创面修复能力,具有较良好的临床应用前景。The invention discloses a collagen-chitosan and silicon rubber double-layer skin regeneration support and a preparation method thereof. The skin regeneration scaffold is formed by bonding a collagen/chitosan porous scaffold and a silicon rubber film through an adhesive with good biocompatibility. Among them, the collagen/chitosan porous scaffold can effectively induce the migration, proliferation and differentiation of cells in the defect tissue, and induce the regeneration of the defect dermal tissue in situ; the silicone rubber film plays the role of a temporary epidermis, which can effectively control the volatilization and Prevent the invasion of bacteria, etc., and play a temporary protective role on the wound surface. The collagen-chitosan/silicone rubber composite scaffold prepared by the invention has good biocompatibility, controllable degradation rate and excellent wound repair ability, and has good clinical application prospect.
Description
技术领域technical field
本发明涉及一种双层皮肤再生支架及其制备方法。具体说涉及胶原—壳聚糖和硅橡胶双层皮肤再生支架及其制备方法。The invention relates to a double-layer skin regeneration support and a preparation method thereof. Specifically, it relates to a collagen-chitosan and silicon rubber double-layer skin regeneration support and a preparation method thereof.
背景技术Background technique
皮肤的烧伤或溃疡是十分常见的外科病症,如各种事故与战争中的创伤及自身疾病如糖尿病引起的皮肤溃烂。皮肤的缺损轻则影响病人的外表美观,重则引发感染或电解质与水分的大量流失,导致病人的死亡。皮肤组织虽然具有较强的再生能力,但是对于大面积的全层皮肤缺损,皮肤就丧失了自发再生的能力。治疗全厚皮缺损的关键是使创面尽早封闭,以减少机体消耗和内环境紊乱,以及微生物入侵等并发症的发生。迄今为止,自体皮移植仍然是临床治疗全层皮肤缺损最有效的方法。但是该方法面临着自体皮供应不足的缺点,如III度烧伤面积超过30%时供皮部位就已不足。Burns or ulcers of the skin are very common surgical diseases, such as wounds in various accidents and wars, and skin ulcers caused by self-diseases such as diabetes. Skin defects can affect the patient's appearance in mild cases, and in severe cases can cause infection or a large loss of electrolytes and water, leading to the death of the patient. Although skin tissue has a strong regenerative ability, for a large area of full-thickness skin defect, the skin loses its ability to spontaneously regenerate. The key to the treatment of full-thickness skin defects is to seal the wound as early as possible, so as to reduce the consumption of the body, the disturbance of the internal environment, and the occurrence of complications such as microbial invasion. So far, autologous skin grafting is still the most effective method for clinical treatment of full-thickness skin defects. However, this method faces the shortcoming of insufficient supply of autologous skin, such as when the third-degree burn area exceeds 30%, the skin donor site is already insufficient.
皮肤是人体最大的器官,约占人体重量的16%,是机体与外界的天然屏障和沟通的桥梁。皮肤的组成与结构具有高度的复杂性,包括多种细胞(表皮细胞、真皮细胞等),胶原纤维、弹性纤维,糖蛋白或蛋白多糖等生物大分子,以及氨基酸、葡萄糖、维生素以及无机盐等小分子。人体的皮肤由表及里可以依次分为表皮、基底膜、真皮以及皮下组织四个部分。其中表皮层和真皮层是实现皮肤功能的最重要组成部分。表皮层属于上皮组织,厚约0.1mm,由10层左右的表皮细胞构成。真皮是一种致密的结缔组织,厚约2~5mm,主要是由成纤维细胞分泌的胶原纤维、弹性纤维以及蛋白多糖等物质构成。真皮层是皮肤发挥功能的最重要结构。皮肤复杂的组成和结构决定了其功能的多样性。皮肤首先是人体与外界环境的天然屏障,它可以避免机体内水分和电解质等物质的丧失,可以保护机体免受外界环境中的辐射、化学物质、细菌以及病毒的直接危害。同时皮肤又是机体与外界环境沟通的桥梁,通过皮肤的代谢可以调节机体内部水分和其它物质的平衡,调节人体体温,并起到感知外界信息的作用。The skin is the largest organ of the human body, accounting for about 16% of the body weight, and is a natural barrier and a bridge of communication between the body and the outside world. The composition and structure of the skin are highly complex, including a variety of cells (epidermal cells, dermal cells, etc.), collagen fibers, elastic fibers, glycoproteins or proteoglycans and other biomacromolecules, as well as amino acids, glucose, vitamins and inorganic salts, etc. Small molecule. Human skin can be divided into four parts from the surface to the inside: the epidermis, basement membrane, dermis, and subcutaneous tissue. Among them, the epidermis and dermis are the most important components to realize skin function. The epidermis is an epithelial tissue with a thickness of about 0.1mm and is composed of about 10 layers of epidermal cells. The dermis is a dense connective tissue with a thickness of about 2-5mm, mainly composed of collagen fibers, elastic fibers and proteoglycans secreted by fibroblasts. The dermis is the most important structure for skin function. The complex composition and structure of the skin determines the diversity of its functions. The skin is first of all a natural barrier between the human body and the external environment. It can prevent the loss of water and electrolytes in the body, and can protect the body from the direct harm of radiation, chemicals, bacteria and viruses in the external environment. At the same time, the skin is the bridge between the body and the external environment. Through the metabolism of the skin, the balance of water and other substances inside the body can be adjusted, the body temperature can be adjusted, and the external information can be sensed.
因此,在皮肤再生材料的设计中,通常应模拟皮肤的表皮和真皮双层结构的特点,设计具有模拟表皮层和真皮层的双层结构。其中真皮层支架起到诱导皮肤真皮再生的作用;而表皮层覆盖物则起到隔离外界环境、避免细菌侵入、防止水分蒸发等作用。Therefore, in the design of skin regeneration materials, the characteristics of the double-layer structure of the epidermis and dermis of the skin should usually be simulated, and the design has a double-layer structure that simulates the epidermis and dermis. Among them, the dermis scaffold plays the role of inducing skin dermis regeneration; while the epidermis covering plays the role of isolating the external environment, preventing bacterial invasion, and preventing water evaporation.
在我国,每年因为烧伤、机械损伤或慢性皮肤溃疡而需要医治的患者高达数千万。因此开发出能有效促进创面愈合与皮肤组织再生的新型皮肤再生支架具有重要的社会效益和经济效益。In my country, there are tens of millions of patients who need medical treatment due to burns, mechanical injuries or chronic skin ulcers every year. Therefore, the development of a new skin regeneration scaffold that can effectively promote wound healing and skin tissue regeneration has important social and economic benefits.
发明内容Contents of the invention
本发明的目的是提供一种能有效促进创面愈合与皮肤组织再生的胶原—壳聚糖和硅橡胶双层皮肤再生支架及其制备方法。The purpose of the present invention is to provide a collagen-chitosan and silicone rubber double-layer skin regeneration support that can effectively promote wound healing and skin tissue regeneration and a preparation method thereof.
本发明的胶原—壳聚糖和硅橡胶双层皮肤再生支架,由胶原—壳聚糖多孔支架和硅橡胶薄膜两部分组成。The collagen-chitosan and silicon rubber double-layer skin regeneration support of the present invention is composed of two parts: a collagen-chitosan porous support and a silicon rubber film.
胶原—壳聚糖和硅橡胶双层皮肤再生支架的制备方法,采用冷冻—冻干法,步骤如下,以下浓度均按质量计:The preparation method of collagen-chitosan and silicone rubber double-layer skin regeneration scaffold adopts freezing-lyophilization method, and the steps are as follows, and the following concentrations are all by mass:
1)用浓度为0.3%~5%的乙酸溶液分别配制浓度为0.1%~1%的胶原溶液和壳聚糖溶液,将壳聚糖溶液滴入胶原溶液中,搅拌均匀真空脱泡,得胶原—壳聚糖混合溶液,其中壳聚糖溶液的含量为5%~50%;1) Use acetic acid solution with a concentration of 0.3% to 5% to prepare collagen solution and chitosan solution with a concentration of 0.1% to 1%, respectively, drop the chitosan solution into the collagen solution, stir evenly, and vacuum defoam to obtain collagen - Chitosan mixed solution, wherein the content of chitosan solution is 5% to 50%;
2)将胶原—壳聚糖共混液注入模具中,采用冷冻—干燥法,在-5℃~-50℃温度下冷冻成固体,得到胶原—壳聚糖三维多孔支架;2) injecting the collagen-chitosan blend into the mold, and freezing it into a solid at -5°C to -50°C by a freeze-drying method to obtain a collagen-chitosan three-dimensional porous scaffold;
3)将步骤2)所得的胶原—壳聚糖三维多孔支架先在80℃~130℃温度下真空干热物理交联处理,再于浓度为0.05%~1%戊二醛溶液中交联1~48小时,反复清洗后,再次冷冻、冻干;3) The collagen-chitosan three-dimensional porous scaffold obtained in step 2) is first subjected to vacuum dry heat physical cross-linking treatment at a temperature of 80° C. to 130° C., and then cross-linked in a glutaraldehyde solution with a concentration of 0.05% to 1%. ~48 hours, after repeated washing, freeze and freeze-dry again;
4)将生物相容性良好的胶粘剂以0.05~0.5mg/cm2的量均匀涂覆在厚度为0.05~0.5毫米的硅橡胶薄膜表面,然后将胶原—壳聚糖真皮支架放在涂覆胶粘剂的硅橡胶薄膜表面上,获得胶原—壳聚糖/硅橡胶双层皮肤再生支架。4) Evenly coat the adhesive with good biocompatibility in the amount of 0.05-0.5mg/ cm2 on the surface of the silicone rubber film with a thickness of 0.05-0.5 mm, and then place the collagen-chitosan dermal scaffold on the coated adhesive The collagen-chitosan/silicone rubber bilayer skin regeneration scaffold was obtained on the surface of the silicone rubber film.
上述的生物相容性良好的胶粘剂可以是α-氰基丙烯酸酯类胶粘剂、纤维蛋白胶或明胶。其中α-氰基丙烯酸酯类胶粘剂可以选用α-氰基丙烯酸丁酯或α-氰基丙烯酸辛酯。所说的胶原是I型胶原,可以是牛腱胶原、猪皮胶原、鼠尾胶原。The above-mentioned adhesive with good biocompatibility may be α-cyanoacrylate adhesive, fibrin glue or gelatin. Among them, the α-cyanoacrylate adhesive can be selected from α-butyl cyanoacrylate or α-octyl cyanoacrylate. Said collagen is type I collagen, which can be bovine tendon collagen, pig skin collagen, or rat tail collagen.
本发明中的胶原—壳聚糖真皮支架,其突出特点是以可生物降解的胶原蛋白为主要原料,添加少量壳聚糖起促进交联、增强与耐降解作用;通过控制冷冻干燥条件,得到具有特定微结构(孔径、孔隙率等)的多孔支架。在材料的选择上,来自于动物体的天然材料如胶原和壳聚糖比合成材料具有更大的优势。I型胶原是真皮细胞外基质(ECM)的主要成分,其分子结构中富含RGD肽,是细胞膜表面整合素(Integrin)的特异性配体,具有促进细胞粘附与生长的功能。I型胶原的来源丰富、提纯容易,免疫原性温和。壳聚糖是甲壳素脱乙酰化的产物,具有抗感染、止痛、促凝血和促进创面愈合的功能,且来源丰富。通过在胶原中添加少量壳聚糖,能够弥补胶原中氨基含量不足的问题,从而有利于胶原的交联,提高其耐降解性能和机械强度。试验表明该支架能够有效促进成纤维细胞和表皮细胞的生长;免疫原性温和,具有良好的组织相容性;动物体内实验发现能够血管化,即能够成活。这种多孔支架可作为组织生长的临时支架,促进创面肉芽组织、成纤维细胞、内皮细胞和表皮细胞在支架的多孔内生长。这些长入的组织或细胞会分泌出相应的细胞外基质进而分化成新的皮肤组织,促进受损皮肤的再生。与此同时,外源性的胶原/壳聚糖多孔膜会随着新生组织的不断发育而逐渐降解,并被机体吸收,最终得到的是与人体自身完全相似的真皮组织。Collagen-chitosan dermis support among the present invention, its outstanding feature is to take biodegradable collagen protein as main raw material, add a small amount of chitosan to promote cross-linking, strengthen and resist degradation; By controlling freeze-drying conditions, obtain Porous scaffolds with specific microstructures (pore size, porosity, etc.). In terms of material selection, natural materials such as collagen and chitosan from animal bodies have greater advantages than synthetic materials. Type I collagen is the main component of dermal extracellular matrix (ECM), and its molecular structure is rich in RGD peptide, which is the specific ligand of integrin (Integrin) on the cell membrane surface and has the function of promoting cell adhesion and growth. Type I collagen is rich in sources, easy to purify, and mild in immunogenicity. Chitosan is the product of deacetylation of chitin, which has the functions of anti-infection, pain relief, promoting blood coagulation and promoting wound healing, and is rich in sources. Adding a small amount of chitosan to the collagen can make up for the lack of amino groups in the collagen, thereby facilitating the cross-linking of the collagen and improving its degradation resistance and mechanical strength. Tests show that the scaffold can effectively promote the growth of fibroblasts and epidermal cells; the immunogenicity is mild and has good tissue compatibility; animal experiments show that it can be vascularized, that is, it can survive. This porous scaffold can be used as a temporary scaffold for tissue growth, and promotes the growth of wound granulation tissue, fibroblasts, endothelial cells and epidermal cells within the pores of the scaffold. These ingrown tissues or cells will secrete the corresponding extracellular matrix and then differentiate into new skin tissue, promoting the regeneration of damaged skin. At the same time, the exogenous collagen/chitosan porous membrane will gradually degrade with the continuous development of the new tissue, and be absorbed by the body, and finally the dermal tissue that is completely similar to the human body is obtained.
本发明选择硅橡胶薄膜作为表皮层的模拟物,因为硅橡胶具有良好的生物相容性,高的透气性和可控透湿性能,同时具有良好的弹性和临床易操作性等。这些特点赋予了硅橡胶薄膜的隔离功能、阻止细菌侵入功能、防止水分蒸发功能等,因此可以起到表皮层的功能,从而保证双层皮肤支架的实用性。In the present invention, the silicone rubber film is selected as the simulant of the epidermis, because the silicone rubber has good biocompatibility, high air permeability and controllable moisture permeability, and has good elasticity and clinical ease of operation. These characteristics give the silicone rubber film the isolation function, the function of preventing bacterial invasion, and the function of preventing water evaporation, etc., so it can play the function of the epidermis, thereby ensuring the practicability of the double-layer skin scaffold.
本发明的胶原—壳聚糖/硅橡胶复合多孔支架具有双层结构特征,其中胶原—壳聚糖多孔支架层可以诱导创面细胞的定向迁移、增殖及分化,原位诱导真皮组织的再生。而硅橡胶薄膜层具有阻止组织水分的挥发、保持创口湿润、防止细菌侵入等功能。生物相容性粘接剂可以实现胶原/壳聚糖多孔支架层和硅橡胶薄膜层的有效粘合,方便了手术的操作,增加了实用性。The collagen-chitosan/silicone rubber composite porous scaffold of the present invention has the characteristics of a double-layer structure, wherein the collagen-chitosan porous scaffold layer can induce directional migration, proliferation and differentiation of wound cells, and induce regeneration of dermal tissue in situ. The silicone rubber film layer has functions such as preventing the volatilization of tissue moisture, keeping the wound moist, and preventing bacterial invasion. The biocompatible adhesive can realize the effective bonding of the collagen/chitosan porous scaffold layer and the silicone rubber film layer, which facilitates the operation of the operation and increases the practicability.
本发明为深度烧伤和慢性皮肤溃疡病人的治疗提供了一种性能良好的皮肤替代物,可以显著促进创面的愈合,减少瘢痕的增生,进而减轻病人的痛苦。可以广泛应用于烧伤创面、外科整形和爆发性紫癜等方面。本发明制备方法简单,材料来源广泛,生产效率高,适用于产业化生产。与国外同类产品相比,本发明产品成本方面具有很大优势。The invention provides a skin substitute with good performance for the treatment of patients with deep burns and chronic skin ulcers, which can significantly promote the healing of wounds, reduce the hyperplasia of scars, and further reduce the pain of patients. It can be widely used in burn wounds, plastic surgery and purpura eruptions. The preparation method of the invention is simple, the source of materials is wide, the production efficiency is high, and it is suitable for industrialized production. Compared with similar foreign products, the product of the present invention has great advantages in terms of cost.
附图说明Description of drawings
图1是胶原—壳聚糖/硅橡胶双层皮肤再生支架整体外观照片;Figure 1 is a photo of the overall appearance of the collagen-chitosan/silicone rubber double-layer skin regeneration scaffold;
图2是胶原—壳聚糖/硅橡胶双层皮肤再生支架微结构图;Fig. 2 is the microstructural diagram of collagen-chitosan/silicone rubber double-layer skin regeneration scaffold;
图3是明胶为胶粘剂的胶原—壳聚糖/硅橡胶双层皮肤再生支架细胞毒性评价结果;Fig. 3 is that gelatin is the collagen-chitosan/silicone rubber double-layer skin regeneration scaffold cytotoxic evaluation result of adhesive agent;
图4是α-氰基丙烯酸酯辛酯为胶粘剂的胶原—壳聚糖/硅橡胶双层皮肤再生支架细胞毒性评价结果;Fig. 4 is the cytotoxicity evaluation result of the collagen-chitosan/silicone rubber double-layer skin regeneration scaffold that octyl cyanoacrylate is an adhesive;
图5是胶原—壳聚糖/硅橡胶双层皮肤再生支架对猪背全层皮肤缺损创面修复4周后的大体观察照片;Fig. 5 is the general observation photo of collagen-chitosan/silicone rubber double-layer skin regeneration scaffold repairing the full-thickness skin defect wound on the pig's back after 4 weeks;
图6是胶原—壳聚糖/硅橡胶双层皮肤再生支架猪背全层皮肤缺损创面修复4周后的组织切片图,标尺为200微米。Fig. 6 is a tissue section diagram of the full-thickness skin defect wound on the pig's back 4 weeks after the collagen-chitosan/silicone rubber double-layer skin regeneration scaffold was repaired, and the scale bar is 200 microns.
具体实施方法Specific implementation method
实施例1:Example 1:
将胶原和壳聚糖分别溶于3%的乙酸溶液中,配制浓度为0.5%的胶原溶液和浓度为0.5%的壳聚糖溶液,将壳聚糖溶液滴入胶原溶液中,其中壳聚糖的含量为10%,搅拌均匀真空脱泡;采用冷冻—冻干法,于-20℃冷冻2小时,然后冷冻干燥24小时。冻干的胶原/壳聚糖支架于105℃的真空干燥箱中真空干热交联12h,于4℃下用0.25%的戊二醛溶液交联24h,用三蒸水反复漂洗后,再次冷冻—冻干获得交联的胶原—壳聚糖多孔支架。在厚约0.14mm的硅橡胶薄膜表面,将生物相容性良好的明胶胶粘剂以0.25mg/cm2的量均匀涂覆在硅橡胶薄膜表面,然后再将胶原—壳聚糖多孔支架轻轻放在涂覆明胶的硅橡胶薄膜表面上,即获得胶原—壳聚糖/硅橡胶双层皮肤再生支架。图1和图2分别为该复合皮肤再生支架的宏观形貌图和微观结构图。Collagen and chitosan were dissolved in 3% acetic acid solution respectively, and the preparation concentration was 0.5% collagen solution and 0.5% chitosan solution, and the chitosan solution was dropped into the collagen solution, wherein the chitosan The content is 10%, stir evenly and vacuum degassing; use freeze-lyophilization method, freeze at -20°C for 2 hours, and then freeze-dry for 24 hours. Freeze-dried collagen/chitosan scaffolds were cross-linked in a vacuum oven at 105°C for 12 hours, cross-linked with 0.25% glutaraldehyde solution at 4°C for 24 hours, rinsed repeatedly with triple distilled water, and then frozen again - freeze-drying to obtain cross-linked collagen-chitosan porous scaffolds. On the surface of the silicone rubber film with a thickness of about 0.14 mm, evenly coat the gelatin adhesive with good biocompatibility in the amount of 0.25 mg/ cm2 on the surface of the silicone rubber film, and then gently place the collagen-chitosan porous scaffold On the surface of the silicone rubber film coated with gelatin, a collagen-chitosan/silicone rubber double-layer skin regeneration scaffold was obtained. Figure 1 and Figure 2 are the macroscopic topography and microstructure diagrams of the composite skin regeneration scaffold, respectively.
实施例2:Example 2:
将胶原和壳聚糖分别溶于3%的乙酸溶液中,配制浓度为0.5%的胶原溶液和浓度为0.5%的壳聚糖溶液,将壳聚糖溶液滴入胶原溶液中,其中壳聚糖的含量为10%,搅拌均匀真空脱泡;采用冷冻—冻干法,于-20℃冷冻2小时,然后冷冻干燥24小时。冻干的胶原—壳聚糖支架于105℃的真空干燥箱中真空干热交联12h,于4℃下用0.25%的戊二醛溶液交联24h,用三蒸水反复漂洗后,再次冷冻—冻干获得交联的胶原—壳聚糖多孔支架。在厚约0.14mm的硅橡胶薄膜表面,将生物相容性良好的α-氰基丙烯酸酯辛酯胶粘剂以0.25mg/cm2的量均匀涂覆在硅橡胶薄膜表面,然后再将胶原—壳聚糖多孔支架轻轻放在涂覆胶的硅橡胶薄膜表面上,即获得胶原—壳聚糖/硅橡胶双层皮肤再生支架。Collagen and chitosan were dissolved in 3% acetic acid solution respectively, and the preparation concentration was 0.5% collagen solution and 0.5% chitosan solution, and the chitosan solution was dropped into the collagen solution, wherein the chitosan The content is 10%, stir evenly and vacuum degassing; use freeze-lyophilization method, freeze at -20°C for 2 hours, and then freeze-dry for 24 hours. Freeze-dried collagen-chitosan scaffolds were cross-linked in a vacuum oven at 105°C for 12 hours, then cross-linked with 0.25% glutaraldehyde solution at 4°C for 24 hours, rinsed repeatedly with three-distilled water, and then frozen again - freeze-drying to obtain cross-linked collagen-chitosan porous scaffolds. On the surface of the silicone rubber film with a thickness of about 0.14 mm, evenly coat the α-cyanoacrylate octyl adhesive with good biocompatibility in the amount of 0.25 mg/ cm2 on the surface of the silicone rubber film, and then apply the collagen-shell The polysaccharide porous scaffold is gently placed on the surface of the gel-coated silicone rubber film to obtain a collagen-chitosan/silicone rubber double-layer skin regeneration scaffold.
实施例3:Example 3:
将胶原和壳聚糖分别溶于0.3%的乙酸溶液中,配制浓度为0.5%的胶原溶液和浓度为0.5%的壳聚糖溶液,将壳聚糖溶液滴入胶原溶液中,其中壳聚糖的含量为5%,搅拌均匀真空脱泡;采用冷冻—冻干法,于-5℃冷冻成固体,然后冷冻干燥24小时。冻干的胶原/壳聚糖支架于80℃的真空干燥箱中真空干热交联12h,于4℃下用0.05%的戊二醛溶液交联1h,用三蒸水反复漂洗后,再次冷冻—冻干获得交联的胶原—壳聚糖多孔支架。在厚约0.05mm的硅橡胶薄膜表面,将生物相容性良好的α-氰基丙烯酸酯辛酯胶粘剂以0.05mg/cm2的量均匀涂覆在硅橡胶薄膜表面,然后再将胶原—壳聚糖多孔支架轻轻放在涂覆胶的硅橡胶薄膜表面上,即获得胶原—壳聚糖/硅橡胶双层皮肤再生支架。Collagen and chitosan were dissolved in 0.3% acetic acid solution respectively to prepare a 0.5% collagen solution and a 0.5% chitosan solution, and the chitosan solution was dropped into the collagen solution, wherein the chitosan The content is 5%, stir evenly and vacuum degassing; use freeze-lyophilization method, freeze to solid at -5°C, and then freeze-dry for 24 hours. Freeze-dried collagen/chitosan scaffolds were cross-linked in a vacuum oven at 80°C for 12 hours, cross-linked with 0.05% glutaraldehyde solution at 4°C for 1 hour, rinsed repeatedly with triple distilled water, and then frozen again - freeze-drying to obtain cross-linked collagen-chitosan porous scaffolds. On the surface of the silicone rubber film with a thickness of about 0.05mm, the α-cyanoacrylate octyl adhesive with good biocompatibility is evenly coated on the surface of the silicone rubber film at an amount of 0.05mg/ cm2 , and then the collagen-shell The polysaccharide porous scaffold is gently placed on the surface of the gel-coated silicone rubber film to obtain a collagen-chitosan/silicone rubber double-layer skin regeneration scaffold.
实施例4:Example 4:
将胶原和壳聚糖分别溶于3%的乙酸溶液中,配制浓度为0.5%的胶原溶液和浓度为0.5%的壳聚糖溶液,将壳聚糖溶液滴入胶原溶液中,其中壳聚糖的含量为50%,搅拌均匀真空脱泡;采用冷冻—冻干法,于-50℃冷冻2小时,然后冷冻干燥24小时。冻干的胶原—壳聚糖支架于130℃的真空干燥箱中真空干热交联12h,于4℃下用1%的戊二醛溶液交联48h,用三蒸水反复漂洗后,再次冷冻—冻干获得交联的胶原—壳聚糖多孔支架。在厚约0.14mm的硅橡胶薄膜表面,将生物相容性良好的纤维蛋白胶粘剂以0.5mg/cm2的量均匀涂覆在硅橡胶薄膜表面,然后再将胶原—壳聚糖多孔支架轻轻放在涂覆胶的硅橡胶薄膜表面上,即获得胶原—壳聚糖/硅橡胶双层皮肤再生支架。Collagen and chitosan were dissolved in 3% acetic acid solution respectively, and the preparation concentration was 0.5% collagen solution and 0.5% chitosan solution, and the chitosan solution was dropped into the collagen solution, wherein the chitosan The content is 50%, stir evenly and vacuum degassing; use freeze-freeze drying method, freeze at -50°C for 2 hours, and then freeze-dry for 24 hours. Freeze-dried collagen-chitosan scaffolds were cross-linked in a vacuum oven at 130°C for 12 hours, then cross-linked with 1% glutaraldehyde solution at 4°C for 48 hours, rinsed repeatedly with triple distilled water, and then frozen again - freeze-drying to obtain cross-linked collagen-chitosan porous scaffolds. On the surface of the silicone rubber film with a thickness of about 0.14 mm, evenly coat the fibrin adhesive with good biocompatibility on the surface of the silicone rubber film at an amount of 0.5 mg/cm 2 , and then gently apply the collagen-chitosan porous scaffold Placed on the surface of the silicone rubber film coated with glue, the collagen-chitosan/silicone rubber double-layer skin regeneration scaffold is obtained.
实施例5:明胶为胶粘剂的胶原—壳聚糖/硅橡胶双层皮肤再生支架的细胞毒性Example 5: Cytotoxicity of collagen-chitosan/silicone rubber double-layer skin regeneration scaffold with gelatin as adhesive
将实施例1得到的胶原—壳聚糖/硅橡胶双层皮肤再生支架经环氧乙烷灭菌后,以添加了10%小牛血清、100单位/毫升青霉素和100单位/毫升的链霉素的DMEM培养液为浸提介质,4℃条件下浸提24小时。以该浸提液为培养液,观察成纤维细胞的活性随时间的变化(图3),证明该双层皮肤再生支架没有细胞毒性。细胞活性采用3-(4,5-二甲基噻唑)-2,5-二苯基四氮唑溴盐(MTT)方法检测。After the collagen-chitosan/silicone rubber double-layer skin regeneration scaffold obtained in Example 1 was sterilized by ethylene oxide, 10% calf serum, 100 units/ml penicillin and 100 units/ml streptavidin were added. The elemental DMEM culture solution was used as the leaching medium, and the leaching was carried out at 4°C for 24 hours. Using the extract as a culture medium, the activity of fibroblasts was observed over time ( FIG. 3 ), which proved that the double-layer skin regeneration scaffold had no cytotoxicity. Cell viability was detected by 3-(4,5-dimethylthiazole)-2,5-diphenyltetrazolium bromide (MTT) method.
实施例6:α-氰基丙烯酸酯辛酯为胶粘剂的胶原—壳聚糖/硅橡胶双层皮肤再生支架的细胞毒性Example 6: Cytotoxicity of collagen-chitosan/silicone rubber double-layer skin regeneration scaffold with α-cyanoacrylate octyl as adhesive
将实施例2得到的胶原—壳聚糖/硅橡胶双层皮肤再生支架经环氧乙烷灭菌后,以添加了10%小牛血清、100单位/毫升青霉素和100单位/毫升的链霉素的DMEM培养液为浸提介质,4℃条件下浸提24小时。以该浸提液为培养液,观察成纤维细胞的活性随时间的变化(图4),证明该双层皮肤再生支架没有细胞毒性。细胞活性采用3-(4,5-二甲基噻唑)-2,5-二苯基四氮唑溴盐(MTT)方法检测。After the collagen-chitosan/silicone rubber double-layer skin regeneration scaffold obtained in Example 2 was sterilized by ethylene oxide, 10% calf serum, 100 units/ml penicillin and 100 units/ml streptavidin were added. The elemental DMEM culture solution was used as the leaching medium, and the leaching was carried out at 4°C for 24 hours. Using the extract as a culture medium, the activity of fibroblasts was observed over time ( FIG. 4 ), which proved that the double-layer skin regeneration scaffold had no cytotoxicity. Cell viability was detected by 3-(4,5-dimethylthiazole)-2,5-diphenyltetrazolium bromide (MTT) method.
实施例7:胶原—壳聚糖/硅橡胶双层皮肤再生支架的体外皮肤再生能力评价Example 7: In vitro skin regeneration ability evaluation of collagen-chitosan/silicone rubber double-layer skin regeneration scaffold
同实例1制备交联的胶原—壳聚糖支架。在厚约0.14mm的硅橡胶薄膜,将生物相容性良好的α-氰基丙烯酸酯辛酯胶粘剂以0.5mg/cm2的量均匀涂覆在硅橡胶薄膜表面,然后再将胶原/壳聚糖多孔支架轻轻放在涂覆胶的硅橡胶薄膜表面上,即获得胶原—壳聚糖/硅橡胶双层皮肤再生支架。该复合再生支架经环氧乙烷灭菌后,移植于猪背部全层皮肤缺损处,经常规打包包扎,分别于术后3、7、14、28天后评价创面愈合情况。图5为移植4周后创面的大体观察,图6为移植4周后的组织切片图,证明真皮组织已经长入支架中。Prepare the cross-linked collagen-chitosan scaffold with Example 1. On a silicone rubber film with a thickness of about 0.14 mm, evenly coat the α-cyanoacrylate octyl adhesive with good biocompatibility on the surface of the silicone rubber film at an amount of 0.5 mg/cm 2 , and then coat the collagen/chitopolymer The sugar porous scaffold is gently placed on the surface of the gel-coated silicone rubber film to obtain a collagen-chitosan/silicone rubber double-layer skin regeneration scaffold. The composite regenerative scaffold was sterilized by ethylene oxide, transplanted to the full-thickness skin defect on the back of the pig, and routinely packed and bandaged. The wound healing was evaluated 3, 7, 14, and 28 days after the operation. Figure 5 is the general observation of the wound 4 weeks after the transplantation, and Figure 6 is a tissue slice picture 4 weeks after the transplantation, which proves that the dermal tissue has grown into the scaffold.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200510061872XA CN1319605C (en) | 2005-12-07 | 2005-12-07 | Collagen-chitin and silicon rubber bilayer skin regeneration support and its preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200510061872XA CN1319605C (en) | 2005-12-07 | 2005-12-07 | Collagen-chitin and silicon rubber bilayer skin regeneration support and its preparation method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1785444A CN1785444A (en) | 2006-06-14 |
CN1319605C true CN1319605C (en) | 2007-06-06 |
Family
ID=36783113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200510061872XA Expired - Fee Related CN1319605C (en) | 2005-12-07 | 2005-12-07 | Collagen-chitin and silicon rubber bilayer skin regeneration support and its preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1319605C (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101254313B (en) * | 2008-04-03 | 2011-05-11 | 厦门大学 | Double-layer collagen-chitosan sponges bracket and method of preparing the same |
CN101874751B (en) * | 2009-04-30 | 2013-07-10 | 复旦大学 | Multi-layer porous scaffold and preparation method thereof |
CN101716376B (en) * | 2009-11-20 | 2014-10-22 | 深圳齐康医疗器械有限公司 | Growth factor slow-release type double-layered artificial skin |
CN102114272A (en) * | 2010-06-04 | 2011-07-06 | 浙江大学 | Method for preparing quaternized chitosan and plasmid DNA compound particle loaded skin regeneration material |
CN102028973B (en) * | 2010-12-31 | 2014-02-26 | 南昌大学 | Preparation method and application of a silicone rubber/collagen-based porous skin scaffold material |
CN102671243A (en) * | 2012-05-10 | 2012-09-19 | 浙江大学 | Quaternized chitosan/siRNA composite particle-loaded skin regeneration material and preparation method thereof |
CN102961786B (en) * | 2012-11-26 | 2014-06-11 | 中国人民解放军第三军医大学第一附属医院 | Porous silicon rubber film for artificial skin |
CN104725829A (en) * | 2013-12-19 | 2015-06-24 | 理大产学研基地(深圳)有限公司 | Polymer blending material with water response shape memory function and preparation method thereof |
CN108079372A (en) * | 2015-06-24 | 2018-05-29 | 安溪县海宏生物科技有限公司 | A kind of preparation method of dermal tissue repair materials |
CN104984407B (en) * | 2015-07-01 | 2017-11-24 | 北京湃生生物科技有限公司 | A kind of tissue engineering artificial skin and preparation method thereof |
CN105944150B (en) * | 2016-03-25 | 2019-05-10 | 华东理工大学 | A kind of hydrogel and artificial skin applying the hydrogel and preparation method thereof |
CN106110400A (en) * | 2016-06-27 | 2016-11-16 | 林春梅 | A kind of skin regeneration material and preparation method thereof |
CN106310359A (en) * | 2016-08-29 | 2017-01-11 | 桂林新艺制冷设备有限责任公司 | Compound biological material |
CN108404209B (en) * | 2018-03-19 | 2022-02-11 | 武汉亚洲生物材料有限公司 | Collagen-fibroin co-assembled sponge material, co-assembled artificial skin and preparation method thereof |
CN109248337B (en) * | 2018-09-19 | 2021-03-30 | 深圳齐康医疗器械有限公司 | Artificial dermis repairing material and preparation method thereof |
CN109529126A (en) * | 2018-10-22 | 2019-03-29 | 深圳齐康医疗器械有限公司 | A kind of artificial dermis and preparation method thereof |
CN112569399B (en) * | 2020-12-11 | 2022-02-01 | 中山大学 | Photo-crosslinking/electrostatic spinning preparation and application of hydrogel composite scaffold with double-layer skin structure |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1319436A (en) * | 2001-02-28 | 2001-10-31 | 中国医学科学院生物医学工程研究所 | Compound collagen stroma tissue engineering support and preparation method thereof |
CN1347736A (en) * | 2000-10-11 | 2002-05-08 | 山东绿叶制药股份有限公司 | Artificial skin and its prepn and use |
JP2002369878A (en) * | 2001-04-13 | 2002-12-24 | Yasuhiko Tabata | Material for internal regeneration of tissue |
CN1386478A (en) * | 2001-05-23 | 2002-12-25 | 中国科学院化学研究所 | Cell scaffold with composite structure for tissue engineering and its preparing process and application |
CN1539514A (en) * | 2003-11-03 | 2004-10-27 | 刘永庆 | Method for preparing multifunctional biological repair material |
US6897245B2 (en) * | 2001-06-21 | 2005-05-24 | Bmg Incorporated | Medical materials sterilized by radiation and their ways in use |
-
2005
- 2005-12-07 CN CNB200510061872XA patent/CN1319605C/en not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1347736A (en) * | 2000-10-11 | 2002-05-08 | 山东绿叶制药股份有限公司 | Artificial skin and its prepn and use |
CN1319436A (en) * | 2001-02-28 | 2001-10-31 | 中国医学科学院生物医学工程研究所 | Compound collagen stroma tissue engineering support and preparation method thereof |
JP2002369878A (en) * | 2001-04-13 | 2002-12-24 | Yasuhiko Tabata | Material for internal regeneration of tissue |
CN1386478A (en) * | 2001-05-23 | 2002-12-25 | 中国科学院化学研究所 | Cell scaffold with composite structure for tissue engineering and its preparing process and application |
US6897245B2 (en) * | 2001-06-21 | 2005-05-24 | Bmg Incorporated | Medical materials sterilized by radiation and their ways in use |
CN1539514A (en) * | 2003-11-03 | 2004-10-27 | 刘永庆 | Method for preparing multifunctional biological repair material |
Also Published As
Publication number | Publication date |
---|---|
CN1785444A (en) | 2006-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sheikholeslam et al. | Biomaterials for skin substitutes | |
CN1319605C (en) | Collagen-chitin and silicon rubber bilayer skin regeneration support and its preparation method | |
Kaur et al. | Biomaterials-based regenerative strategies for skin tissue wound healing | |
Chouhan et al. | Silk biomaterials in wound healing and skin regeneration therapeutics: From bench to bedside | |
Rahmani Del Bakhshayesh et al. | Recent advances on biomedical applications of scaffolds in wound healing and dermal tissue engineering | |
Mir et al. | Synthetic polymeric biomaterials for wound healing: a review | |
Priya et al. | Skin tissue engineering for tissue repair and regeneration | |
Goodarzi et al. | Tissue engineered skin substitutes | |
Haldar et al. | Bioengineered smart trilayer skin tissue substitute for efficient deep wound healing | |
Hodge et al. | Evaluating polymeric biomaterials to improve next generation wound dressing design | |
Morgado et al. | Asymmetric membranes as ideal wound dressings: An overview on production methods, structure, properties and performance relationship | |
Chvapil | Considerations on manufacturing principles of a synthetic burn dressing: a review | |
Sultan et al. | Silk fibroin in wound healing process | |
Basu et al. | Wound healing materials–a perspective for skin tissue engineering | |
Sezer et al. | Biopolymers as wound healing materials: challenges and new strategies | |
Ma et al. | Stem from nature: Bioinspired adhesive formulations for wound healing | |
CN105031740B (en) | A kind of biomimetic prosthetic skin with waterproof and breathable function and preparation method thereof | |
ES2934158T3 (en) | Bioactive collagen biomaterials and methods for their manufacture | |
US20100074874A1 (en) | Synthetic multi-layer structures comprising biopolymer fibres | |
Shen et al. | Bilayer silk fibroin/sodium alginate scaffold promotes vascularization and advances inflammation stage in full-thickness wound | |
Alizadeh et al. | PDGF and VEGF-releasing bi-layer wound dressing made of sodium tripolyphosphate crosslinked gelatin-sponge layer and a carrageenan nanofiber layer | |
CN109731130B (en) | A method for preparing hydrogel wound dressings by low-temperature bio-3D printing technology | |
CN101234215A (en) | Cell-free composite artificial skin and its preparation method | |
Ghosh et al. | Single unit functionally graded bioresorbable electrospun scaffold for scar-free full-thickness skin wound healing | |
JP4273450B2 (en) | Tissue regeneration substrate, transplant material, and production method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070606 Termination date: 20201207 |
|
CF01 | Termination of patent right due to non-payment of annual fee |